Courses | Page 6 | AUA University

Topic

Core Curriculum Related Education

Title	Category	Credit	Event Date	Price
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2024)		4.75 AMA PRA Category 1 Credit™ 4.75 Non-Physician Participation		$0.00	This comprehensive, interactive course equips urologic professionals with the knowledge and skills needed to effectively manage patients with advanced prostate cancer. Through an in-depth exploration of guidelines, treatment modalities, and emerging therapies, participants will gain a thorough understanding of this complex disease and its evolving landscape.
Update Series (2021): Test Your Knowledge Lessons 1-5				$0.00	For our annual subscribers, we are excited to continue to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.This new feature:
Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer Podcast (2023)		0.50 AMA PRA Category 1 Credit™ 0.50 Non-Physician Participation		$0.00	Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is offering phase two of an educational series to update urologists and advanced practice providers (APPs) on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. Part II will consist of two live webinars, one designed specifically for urologists and the other for APPs. The live virtual courses will feature a multidisciplinary panel engaging in a lively discussion on this topic.
AUA Advanced Prostate Cancer Guidelines Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	This course will be comprehensive AUA Guidelines on advanced prostate cancer in the management and outcomes of men with advanced, metastatic and castrate-resistant prostate cancer (CRPC). The course will include risk stratification, germline testing, PET imaging, the use of androgen deprivation therapy in combination with novel androgen axis therapy and chemotherapy in men with newly diagnosed metastatic hormone-sensitive prostate cancer. Early treatment intensification and evidenced-based guidelines will be covered.
Update Series (2021): Test Your Knowledge Lessons 31-35				$0.00	For our annual subscribers, we are excited to continue to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.This new feature:
AUA2023 Highlights in Prostate Cancer (2023)		1.25 AMA PRA Category 1 Credit™ 1.25 Non-Physician Participation		$0.00	To better meet the educational needs of urologists and urologic healthcare providers, the AUA gathered from a variety of sources, including comprehensive literature searches and membership surveys to determine where gaps exist in the knowledge, proficiency, and practice in regards to prostate cancer. This scientific, peer-reviewed publication captures various elements of the AUA Annual Meeting pertaining to prostate cancer including plenary sessions and courses, and reproduces them into a monograph.
Incorporating Genomic Testing and Advanced Imaging For Prostate Cancer Into Your Practice Webcast (2024)		2.00 AMA PRA Category 1 Credit™ 2.00 Non-Physician Participation		$0.00	There are multiple genomic tests and advanced imaging modalities (MRI, prostate-specific membrane antigen PET, etc.) currently available for men to detect and risk-stratify prostate cancer. The outcomes of these tests may lead to different detection strategies (observation, immediate biopsy, etc.) and treatment decisions (active surveillance, surgery, radiation, adjuvant therapy, etc.). We will also discuss germline testing as inherited mutations have considerable implications for screening, treatment, genetic counseling and cascade testing of family members.

Pages